American Bio Medica Quick Ratio (ABMC) starting from the first quarter 2023 to first quarter 2022, Financial Strength Trends, Rankings, Financial Ratios - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• Quick Ratio
• Working Capital
• LT Debt to Equity
• Debt to Equity
• Leverage Ratio
• Tangible Leverage
• Interest Coverage
• Debt Coverage
• Work. Cap. Per Revenue
American Bio Medica Corporation  (ABMC)

American Bio Medica's Quick Ratio

ABMC's quarterly Quick Ratio and Cash & cash equivalent, Current Liabilities growth


American Bio Medica's Cash & cash equivalent grew by 100 % in the Q1 2023 sequentially, while Current Liabilities decreased, this led to improvement in American Bio Medica's Quick Ratio to 0.06, Quick Ratio remained below American Bio Medica Corporation average.

Within Major Pharmaceutical Preparations industry 604 other companies have achieved higher Quick Ratio than American Bio Medica in first quarter 2023. While Quick Ratio total ranking has improved so far during the Q1 2023 to 5028, from total ranking in the fourth quarter 2022 at 5662.

Explain Quick Ratio?
How much Cash & cash equivalents ABMC´s has?
What are ABMC´s Current Liabilities?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

ABMC Quick Ratio (Mar 31 2023)
Q1		 (Dec 31 2022)
Q4		 (Sep 30 2022)
Q3		 (Jun 30 2022)
Q2		 (Mar 31 2022)
Q1
Y / Y Current Liabilities Change -61.09 % 27.55 % 6.83 % -4.67 % -9.35 %
Y / Y Cash & cash equivalent Change 300 % -70.43 % -75.61 % -93.33 % -73.02 %
Quick Ratio MRQ 0.06 0.01 0 0 0.01
ABMC's Total Ranking # 5028 # 5662 # 5662 # 5063 # 5464
Seq. Current Liabilities Change -68.99 % 12.84 % 7.77 % 3.17 % 1.66 %
Seq. Cash & cash equivalent Change 100 % 240 % 400 % -88.24 % -85.22 %



Quick Ratio first quarter 2023 Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 605
Healthcare Sector # 1165
Overall Market # 5028


Quick Ratio Statistics
High Average Low
0.26 0.07 0
(Mar 31 2015)   (Mar 31 2013)




Financial Statements
American Bio Medica's Current Liabilities $ 1 Millions Visit ABMC's Balance sheet
American Bio Medica's Cash & cash equivalent $ 0 Millions Visit ABMC's Balance sheet
Source of ABMC's Sales Visit ABMC's Sales by Geography


Cumulative American Bio Medica's Quick Ratio

ABMC's Quick Ratio for the trailling 12 Months

ABMC Quick Ratio

 (Mar 31 2023)
12 Months		 (Dec 31 2022)
12 Months		 (Sep 30 2022)
12 Months		 (Jun 30 2022)
12 Months		 (Mar 31 2022)
12 Months
Y / Y Current Liabilities TTM Growth -7.78 % 4.48 % 5.02 % 3.35 % 4.38 %
Y / Y Cash & cash equivalent TTM Growth -43.84 % -74.7 % -37.93 % -30.56 % -54.59 %
Quick Ratio TTM 0.01 0 0.01 0.02 0.02
Total Ranking TTM # 4675 # 4678 # 4296 # 4672 # 4642
Seq. Current Liabilities TTM Growth -13.89 % 6.57 % 1.75 % -1.23 % -2.45 %
Seq. Cash & cash equivalent TTM Growth 80.95 % -56.25 % -17.71 % -13.79 % -18.47 %

Quick ratio ranking by company, industry and sector >> Back to ABMC Financial Strength Comparisons >> Go to Compare ABMC Quick Ratio to its Competitors

On the trailing twelve months basis ABMC Cash & cash equivalent more than doubled by 300 % in Q1 2023 year on year, while Current Liabilities dropped to $1 millions, this led to